Detalhe da pesquisa
1.
Patient-Specific Measurable Residual Disease Markers Predict Outcome in Patients With Myelodysplastic Syndrome and Related Diseases After Hematopoietic Stem-Cell Transplantation.
J Clin Oncol
; 42(12): 1378-1390, 2024 Apr 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38232336
2.
CD20 antibodies induce production and release of reactive oxygen species by neutrophils.
Blood
; 123(25): 4001-2, 2014 Jun 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-24948624
3.
Tumour-loaded α-type 1-polarized dendritic cells from patients with chronic lymphocytic leukaemia produce a superior NK-, NKT- and CD8+ T cell-attracting chemokine profile.
Scand J Immunol
; 74(3): 318-326, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21595737
4.
Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Myelomonocytic Leukemia: Clinical and Molecular Genetic Prognostic Factors in a Nordic Population.
Transplant Cell Ther
; 27(12): 991.e1-991.e9, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34500124
5.
Idelalisib Rescues Natural Killer Cells from Monocyte-Induced Immunosuppression by Inhibiting NOX2-Derived Reactive Oxygen Species.
Cancer Immunol Res
; 8(12): 1532-1541, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32967913
6.
The expression of NK cell inhibitory receptors on cytotoxic T cells in B-cell chronic lymphocytic leukaemia (B-CLL).
Ann Hematol
; 86(2): 89-94, 2007 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-17043777
7.
NOX2-dependent immunosuppression in chronic myelomonocytic leukemia.
J Leukoc Biol
; 102(2): 459-466, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28292946
8.
Evaluation of clinical staging in chronic lymphocytic leukemia- population-based study.
Leuk Lymphoma
; 47(12): 2505-16, 2006 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-17169795
9.
Reactive oxygen species induced by therapeutic CD20 antibodies inhibit natural killer cell-mediated antibody-dependent cellular cytotoxicity against primary CLL cells.
Oncotarget
; 7(22): 32046-53, 2016 May 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-27097113
10.
Role of the ERK pathway for oxidant-induced parthanatos in human lymphocytes.
PLoS One
; 9(2): e89646, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24586933
11.
Improved outcome for very elderly patients with diffuse large B-cell lymphoma in the immunochemotherapy era.
Leuk Lymphoma
; 53(3): 394-9, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21864039